BMS 1612

Generic Name: entecavir

Pill imprint BMS 1612 has been identified as Baraclude 1 mg.

Baraclude is used in the treatment of hepatitis b and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy.

Baraclude 1 mg is not subject to the Controlled Substances Act.
See also related documents.

Baraclude Images

Generic Name:
entecavir
Imprint:
BMS
1612
Strength:
1 mg
Color:
Pink
Shape:
Three-sided
Availability:
Prescription only
Inactive Ingredients:
lactose monohydrate
microcrystalline cellulose
crospovidone
povidone
magnesium stearate
titanium dioxide
hypromelloses
polyethylene glycol 400
ferric oxide red
Drug Class:
Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Bristol-Myers Squibb
National Drug Code (NDC):
00003-1612

View Drug DetailsPrint Page

Baraclude 1 mg BMS 1612 Front
Baraclude 1 mg BMS 1612 Back
Baraclude 1 mg BMS 1612
Advertisement

Baraclude is associated with the treatment of:

Search Again

Search by Imprint, Shape or Color

Note: All fields optional. Use the pill finder to identify medications by visual appearance or name.

Imprint:
Color:
Shape:

Search by Drug Name

Drug Name:

Search by National Drug Codes (NDC)

Did you find this page helpful? Yes No

(web5)